May 2017

Big advances in treatment can’t make up for an inability to stop new infections, which number 5,000 per day worldwide.

As the repeal of the Affordable Care Act remains stalled in the US government, action plans are being put into place to address other major areas that are affecting the health of the American public.

Experts explore how to develop and deliver effective prevention and treatment methods.

What can healthcare providers do to stop these infections before they start?

Should clinicians be extra vigilant when deciding who receives antiviral therapy, or are the adverse effects few and infrequent?

Contagion® Editorial Advisory Board member, Khalid Eljaaly, PharmD, BCPS, CAPP, discusses key updates in the Infectious Diseases Society of America and the American Thoracic Society recommendations.

Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.